Feedback on orthopaedic devices

ArthroplastyWatch—beyond borders, beyond compliance

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f1013 (Published 19 February 2013)
Cite this as: BMJ 2013;346:f1013

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Lars Lidgren, professor of orthopaedics1,
  2. Ann Alriksson-Schmidt, research coordinator1,
  3. Jonas Ranstam, professor of medical statistics1
  1. 1Lund University, Department of Orthopaedics, University Hospital, SE-221 85 Lund, Sweden
  1. lars.lidgren{at}med.lu.se

It is now clear that national regulatory and professional bodies do not pay due attention to unfavourable or negative results regarding specific devices, new surgical techniques, and treatments.1 As a result, action is delayed. Communication of adverse events or product recalls does not travel well across borders. Worse still, it can take months or even years before practising surgeons learn about …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL